Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide in Polymyalgia Rheumatica
NCT03576794Phase 3Unknown
- Start
- Mar 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of leflunomide in polymyalgia rheumatica (PMR). Status: unknown.
02
Drugs
leflunomide
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NCT03576794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03576794.